These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 16703262)
1. Essential role of c-Jun-NH2-terminal kinase on synergy induction of apoptosis by TRAIL plus ADM in ADM resistant MCF-7/ADM cells. Li F; Meng L; Xing H; Zhou J; Wang S; Huang L; Xu G; Zhu H; Lu Y; Ma D Apoptosis; 2006 Jul; 11(7):1239-46. PubMed ID: 16703262 [TBL] [Abstract][Full Text] [Related]
2. c-Jun N-terminal kinase contributes to apoptotic synergy induced by tumor necrosis factor-related apoptosis-inducing ligand plus DNA damage in chemoresistant, p53 inactive mesothelioma cells. Vivo C; Liu W; Broaddus VC J Biol Chem; 2003 Jul; 278(28):25461-7. PubMed ID: 12707267 [TBL] [Abstract][Full Text] [Related]
3. Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells. Cuello M; Ettenberg SA; Nau MM; Lipkowitz S Gynecol Oncol; 2001 Jun; 81(3):380-90. PubMed ID: 11371126 [TBL] [Abstract][Full Text] [Related]
4. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin. Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094 [TBL] [Abstract][Full Text] [Related]
5. 1-Methoxy-canthin-6-one induces c-Jun NH2-terminal kinase-dependent apoptosis and synergizes with tumor necrosis factor-related apoptosis-inducing ligand activity in human neoplastic cells of hematopoietic or endodermal origin. Ammirante M; Di Giacomo R; De Martino L; Rosati A; Festa M; Gentilella A; Pascale MC; Belisario MA; Leone A; Turco MC; De Feo V Cancer Res; 2006 Apr; 66(8):4385-93. PubMed ID: 16618764 [TBL] [Abstract][Full Text] [Related]
6. C-jun N-terminal kinase activation is required for apoptotic cell death induced by TNF-related apoptosis-inducing ligand plus DNA-damaging agents in sarcoma cell lines. Mikami T; Koyama T; Koyama T; Imakiire A; Yamamoto K; Furuhata M; Toyota H; Mizuguchi J Anticancer Res; 2006; 26(2A):1153-60. PubMed ID: 16619517 [TBL] [Abstract][Full Text] [Related]
7. The differential sensitivity of Bc1-2-overexpressing human breast tumor cells to TRAIL or doxorubicin-induced apoptosis is dependent on Bc1-2 protein levels. Ruiz de Almodóvar C; Ruiz-Ruiz C; Muñoz-Pinedo C; Robledo G; López-Rivas A Oncogene; 2001 Oct; 20(48):7128-33. PubMed ID: 11704839 [TBL] [Abstract][Full Text] [Related]
8. Adriamycin sensitizes the adriamycin-resistant 8226/Dox40 human multiple myeloma cells to Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-mediated (TRAIL) apoptosis. Jazirehi AR; Ng CP; Gan XH; Schiller G; Bonavida B Clin Cancer Res; 2001 Dec; 7(12):3874-83. PubMed ID: 11751478 [TBL] [Abstract][Full Text] [Related]
9. Cooperative cytotoxicity of proteasome inhibitors and tumor necrosis factor-related apoptosis-inducing ligand in chemoresistant Bcl-2-overexpressing cells. Nencioni A; Wille L; Dal Bello G; Boy D; Cirmena G; Wesselborg S; Belka C; Brossart P; Patrone F; Ballestrero A Clin Cancer Res; 2005 Jun; 11(11):4259-65. PubMed ID: 15930365 [TBL] [Abstract][Full Text] [Related]
10. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5. Park SJ; Wu CH; Choi MR; Najafi F; Emami A; Safa AR Biochem Pharmacol; 2006 Jul; 72(3):293-307. PubMed ID: 16753135 [TBL] [Abstract][Full Text] [Related]
11. [Synergistic induction of apoptosis by the combination of TRAIL and low dose adriamycin in human osteosarcoma cell line U2OS]. Yang DS; Miao XD; Ye ZM; Xu YS Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):595-7. PubMed ID: 16438867 [TBL] [Abstract][Full Text] [Related]
12. Role of intracellular glutathione in cell sensitivity to the apoptosis induced by tumor necrosis factor {alpha}-related apoptosis-inducing ligand/anticancer drug combinations. Meurette O; Lefeuvre-Orfila L; Rebillard A; Lagadic-Gossmann D; Dimanche-Boitrel MT Clin Cancer Res; 2005 Apr; 11(8):3075-83. PubMed ID: 15837763 [TBL] [Abstract][Full Text] [Related]
16. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells. Izeradjene K; Douglas L; Delaney A; Houghton JA Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455 [TBL] [Abstract][Full Text] [Related]
17. Ribotoxic stress sensitizes glioblastoma cells to death receptor induced apoptosis: requirements for c-Jun NH2-terminal kinase and Bim. Xia S; Li Y; Rosen EM; Laterra J Mol Cancer Res; 2007 Aug; 5(8):783-92. PubMed ID: 17699104 [TBL] [Abstract][Full Text] [Related]
18. c-Jun NH2-terminal kinase-mediated up-regulation of death receptor 5 contributes to induction of apoptosis by the novel synthetic triterpenoid methyl-2-cyano-3,12-dioxooleana-1, 9-dien-28-oate in human lung cancer cells. Zou W; Liu X; Yue P; Zhou Z; Sporn MB; Lotan R; Khuri FR; Sun SY Cancer Res; 2004 Oct; 64(20):7570-8. PubMed ID: 15492284 [TBL] [Abstract][Full Text] [Related]
19. Synergistic antitumor effect of TRAIL and adriamycin on the human breast cancer cell line MCF-7. Cui DD; Huang Y; Mao SH; Chen SC; Qiu M; Ji LL; Yi C Braz J Med Biol Res; 2009 Sep; 42(9):854-62. PubMed ID: 19738990 [TBL] [Abstract][Full Text] [Related]
20. Pretreatment of acetylsalicylic acid promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by down-regulating BCL-2 gene expression. Kim KM; Song JJ; An JY; Kwon YT; Lee YJ J Biol Chem; 2005 Dec; 280(49):41047-56. PubMed ID: 16199534 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]